Envista Holdings Corporation reports recurring developments as a global dental products company serving dental professionals through consumables, technologies, equipment and services. Its public updates center on quarterly results, core sales trends, adjusted earnings measures, cash flow, share repurchase activity and management presentations at healthcare conferences.
Company news also covers product and brand activity across DEXIS, Kerr, Nobel Biocare and Ormco, including dental implants, orthodontics, digital imaging, restorative and endodontic solutions. Recent product announcements include Kerr Dental's ZenSeal Pro with ZenSave Tips, reflecting Envista's focus on dental workflow, treatment technology and clinician-facing product commercialization.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Envista Holdings Corporation (NYSE: NVST) will release its first-quarter 2023 financial results on May 3, 2023. A conference call discussing these results is scheduled for the same day at 2:00 PM PT, lasting approximately one hour. The call will be accessible via a dial-in number and will also be webcast on the company's website. Post-presentation, a replay will be available for one year. Envista is a leading global dental products company, supporting professionals with a diverse portfolio that includes dental implants, orthodontics, and digital imaging technologies.